Clayton Financial Group LLC Novo Nordisk A S Transaction History
Clayton Financial Group LLC
- $137 Billion
- Q3 2025
A detailed history of Clayton Financial Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clayton Financial Group LLC holds 50 shares of NVO stock, worth $2,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$2,804% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,723Shares Held
313MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.06 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$826 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$801 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$705 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$652 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $127B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...